AI-generated summary
The authors describe a planned two-year randomised controlled trial of bright light therapy, delivered by a home device, to slow myopia progression in Chinese schoolchildren aged 7 to 12. The study protocol reports no results, and the abstract states that efficacy of such treatments is moderate and that bright light exposure has shown a protective effect in animal models and in natural sunlight.
- Who or what was studied
- Chinese schoolchildren aged 7-12 years
- Limits stated in the abstract
- This is a study protocol only, so no efficacy results are reported, and dosage is measured indirectly by a sensor rather than a wearable light meter.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjophth.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Myopia, Light-emitting diode, Lux, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.